KLK3 and pachyonychia congenita: Eighty-four UK PC patient and 62 control sera (from men with low prostate-specific antigen (PSA) or high PSA with a negative biopsy) were tested for the presence of anti-XMRV antibodies using a neutralisation assay that has been previously described [11].